Literature DB >> 12901592

Immunogenicity of Twinrix in older adults: a critical analysis.

Michel Stoffel1, Marc Lievens, Ilse Dieussaert, Isabelle Martin, Francis André.   

Abstract

Twinrix (GlaxoSmithKline Biologicals, Rixensart, Belgium) is the first combined vaccine to provide protection against both hepatitis A and B. This review presents a critical analysis of antibody responses stratified by age following vaccination with Twinrix in 264 adults aged above 40 years. A month after completion of a 0-, 1-, 6-month vaccination schedule with Twinrix, a good response was observed for both anti-HAV and anti-HBs serum antibodies, suggesting that is an effective vaccine in older adults.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12901592     DOI： 10.1586/14760584.2.1.9

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


  8 in total

1.  Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities.

Authors:  Rania A Tohme; Debo Awosika-Olumo; Carrie Nielsen; Salma Khuwaja; Jennifer Scott; Jian Xing; Jan Drobeniuc; Dale J Hu; Cynthia Turner; Toni Wafeeg; Umid Sharapov; Philip R Spradling
Journal:  Vaccine       Date:  2011-10-18       Impact factor: 3.641

Review 2.  Old and new adjuvants for hepatitis B vaccines.

Authors:  Geert Leroux-Roels
Journal:  Med Microbiol Immunol       Date:  2014-12-19       Impact factor: 3.402

3.  Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adults.

Authors:  Huai Wang; Binyu Cai; Delong Rao; Min Liu; Yabin Li; Xiaofeng Liang; Fuqiang Cui; Guomin Zhang; Fuzhen Wang; Xinghuo Pang; Li Nie; Qian Qiu; Jiang Wu; Liqiu Li; Fang Huang; Wei Zhang
Journal:  Hum Vaccin Immunother       Date:  2016-11       Impact factor: 3.452

4.  Severe necrotizing pancreatitis following combined hepatitis A and B vaccination.

Authors:  Eran Shlomovitz; Ward Davies; Ewa Cairns; William C Brintnell; Mark Goldszmidt; George K Dresser
Journal:  CMAJ       Date:  2007-01-30       Impact factor: 8.262

Review 5.  Correlates of GLA family adjuvants' activities.

Authors:  Steven G Reed; Darrick Carter; Corey Casper; Malcolm S Duthie; Christopher B Fox
Journal:  Semin Immunol       Date:  2018-10-23       Impact factor: 11.130

6.  Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility--Virginia, 2010.

Authors:  Thomas John Bender; Umid Sharapov; Okey Utah; Jian Xing; Dale Hu; Jolanta Rybczynska; Jan Drobeniuc; Saleem Kamili; Philip R Spradling; Anne C Moorman
Journal:  Vaccine       Date:  2013-12-23       Impact factor: 3.641

7.  Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis.

Authors:  Olivier Van Der Meeren; Priya Crasta; Brigitte Cheuvart; Marc De Ridder
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 8.  Vaccines for the elderly: current use and future challenges.

Authors:  Birgit Weinberger
Journal:  Immun Ageing       Date:  2018-01-22       Impact factor: 6.400
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.